Pulling SEC filings + quote and writing the call…

Cushman & Wakefield Ltd.
Next earnings Aug 3, 2026 · consensus $0.35 EPS, $2.67B rev
Last earnings -4.2% on 2026-05-07
Cyclical CRE-services recovery hidden by a one-time impairment — operating income, EBITDA and cash flow all surged while debt fell.
Revenue (FY2025) $10.3B · FY2025
The fundamentals carry the rating, but the price is rich (~82% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.
The headline scares — net income fell 33% to $88.2M and EPS dropped to $0.38, putting the P/E at a rich-looking 36x. But the MD&A tells you that decline is almost entirely a single non-cash event: a $177.0M other-than-temporary impairment on the Greystone JV. Strip the optics and the underlying engine accelerated — operating income rose 33.5% to $453M, Adjusted EBITDA rose 13% to $656.2M, and operating cash flow jumped 63.7% to $340.4M. Revenue grew 8.9% to $10.3B with every service line up: Capital markets +19%, Leasing +8%, Valuation +9%, Services +4%. Capital-markets re-acceleration is the classic early-cycle tell for commercial real estate, and management frames 2025 as a 'higher number of brokerage transactions' year as rates and credit conditions thaw.
The balance sheet is moving the right way. Management completed three Term Loan repricings (lowest credit spread in company history), voluntarily prepaid $300M of principal, cut long-term debt 10.7% to $2.62B, grew equity 11.4%, and ended with $1.8B of liquidity ($1.0B undrawn revolver + $0.8B cash). Leverage at 2.93x liabilities/equity is still high and the -$898M accumulated deficit reflects past pain, but the direction is deleveraging into a recovery, not stress. On valuation, the 0.3x P/S is the more honest lens for an asset-light, fee-based services firm than a one-year impaired P/E; you are paying very little for a $10.3B revenue franchise whose normalized earnings power (FY2024 delivered $0.56 EPS without this year's charge) is well above the reported $0.38.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:38 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $9.39B | $10.1B | $9.49B | $9.45B | $10.3B |
| Gross profit | — | — | — | — | — |
| Operating income | $497M | $535M | $206M | $339M | $453M |
| Net income | $250M | $196M | -$35.4M | $131M | $88.2M |
| Diluted EPS | $1.10 | $0.86 | -$0.16 | $0.56 | $0.38 |
| Net margin | 2.7% | 1.9% | -0.4% | 1.4% | 0.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Entered material agreement + new debt obligation (1.01/2.03); likely term-loan refinancing
Other-events disclosure (item 8.01); no financial impact specified
Other-events disclosure (item 8.01); no financial impact specified
Annual meeting vote results + board/exec change (5.07/5.02); routine governance
Q1 2026 results (period Mar 31); latest interim filing
Q1 2026 results (period Mar 31); latest interim filing
Other-events disclosure (item 8.01); no financial impact specified
FY25 rev +9% to $10.3B, Adj EBITDA +13%; net income -33% on $177M Greystone JV impairment
Sources: SEC EDGAR (CIK 0001628369, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/29/2026, 10:38:00 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-04 | Robinson Nathaniel See Remarks | Sell | 24.8K @ $13.25 | $329K |
| 2026-06-01 | FELMAN MICHELLE Director | Gift | 17.0K | |
| 2026-06-01 | FELMAN MICHELLE Director | Gift | 17.0K | |
| 2026-05-15 | FELMAN MICHELLE Director | Exercise | 17.0K | |
| 2026-05-15 | Williamson Billie Ida Director | Exercise | 17.0K | |
| 2026-05-15 | McLean Jodie W. Director | Exercise | 17.0K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.